Commentary Archive RSS

MAP Pharmaceuticals (Nasdaq: MAPP) Investors Betting on another Cinderella Story

After jumping $5.85, or 186%, on Tuesday, and $3.93, or 43.67% yesterday, shares of Map Pharmaceuticals surged nearly 6% to $12.85 this morning, fueled by word of its migraine treatment, Levadex. Fast buck operators and long-term investors alike jumped on this Cinderella story in the hopes that Map Pharmaceuticals Inc.’s new migraine treatment Levadex(TM) actually [...]

Adventure Energy (OTCBB: ADVE) to Acquire 50% Interest in Petrowarrior Stout Project in Oklahoma

CEO Optimistic Firming Energy Prices Benefit the Company’s Long-Term Potential Adventure Energy Inc., an energy exploration company operating in the Appalachian Basin, recently announced it has signed a Letter of Intent to acquire 50% working interest in Buccaneer Energy’s Petrowarrier-Stout recompletion project located in Pottawatomie and Seminole Counties, Okla., approximately 75 miles east of Oklahoma [...]

Clear Choice Health Plans (OTCBB: CCHN) Posts 2009 First-Quarter Earnings

Revenue Up, Income Down; Cash Sharply Higher Clear Choice Health Plans, as its name implies, offers a variety of voluntary health benefits and insurance to individuals and businesses. The company recently posted its financial results for the first quarter ended March 31, 2009. The Bend, Ore.-based company reported revenue of $57.5 million, up 9.3% from [...]

Adventure Energy (OTCBB: ADVE) to Acquire 50% Interest in Petrowarrior Stout Project in Oklahoma

CEO Optimistic Firming Energy Prices Benefit the Company’s Long-Term Potential Adventure Energy Inc., an energy exploration company operating in the Appalachian Basin, recently announced it has signed a Letter of Intent to acquire 50% working interest in Buccaneer Energy’s Petrowarrier-Stout recompletion project located in Pottawatomie and Seminole Counties, Okla., approximately 75 miles east of the [...]

Cree Inc. (Nasdaq: CREE) – Cree Ups Q4 Outlook on Stronger-than-expected Orders

Stronger LED component and chip bookings push Cree to improve view; CEO expresses optimism in LED lighting’s growth potential. Cree Inc. recently announced an improved revenue and earnings outlook for its fourth quarter, attributed to stronger orders for both lighting and laptop LED products. The improved guidance came in even if demand from automobile, cell [...]

BioNeutral Group Inc. (OTCBB: BONU) – Mr. Mold to Utilize BioNeutral’s Mold Formulation

Mold remediation and restoration company utilizes BioNeutrals’ unique formulation designed for use with mold and mold spores; company expected to place orders immediately. BioNeutral Group Inc. boasts of a novel combinational chemistry that can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses and spores. Its formulations are green and include natural and [...]

Terremark (Nasdaq: TMRK) Shares Jump Sharply on Mixed News

Terremark news beset investors after the close yesterday and this morning as a jumbled earnings report and announcement of an equity stake in the company gyrated its stock price higher by 30 cents on tremendous volume, quadrupling the average activity in the stock. Prior to the slew of news, shares of Terremark had already moved [...]

Stock Alert Simtrol (OTCBB: SMRL) – Simtrol Poised to Benefit from Re-ignition of Higher Energy Prices

To understand the hidden value of Simtrol, one of the fundamentals behind this company’s long-term potential lies in the ultimate fate of the cost of energy. High energy costs are coming back into fashion, and a lot sooner than many now believe. The return of the debate on the best way to respond to the [...]

Cellceutix Corp. (CTIX) Files for Patent Protection

New Compound Holds Promise of a Therapy for Some Cancers Cellceutix Corp. (OTCBB: CTIX) announced it has filed for patent protection with the U.S. Patent and Trademark Office covering pharmaceutical formulations for the company’s new cancer drug candidate, Kevetrin ™, and similar compounds. The company said the various compounds cover possible drug candidates for the [...]

Founder of Styx, Chuck Panozzo, Joins GeoVax (GOVX) as Advocate for the Company’s Promising HIV/AIDS Vaccine

Panozzo Brings Shown Commitment to the HIV/AIDS Cause GeoVax Labs Inc. (OTCBB: GOVX), a biopharmaceutical company developing vaccines for diseases caused by HIV-1, recently announced Chuck Panozzo, founder of the rock band Styx, has joined the company as an advocate for the company’s HIV/AIDS vaccine, which is currently in phase IIa trials. Panozzo said he [...]